Detalles de la búsqueda
1.
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
J Headache Pain
; 22(1): 81, 2021 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34301173
2.
A Controlled Trial of Erenumab for Episodic Migraine.
N Engl J Med
; 377(22): 2123-2132, 2017 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29171821
3.
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response.
Headache
; 60(9): 2026-2040, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32851644
4.
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
Cephalalgia
; 38(10): 1622-1631, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30086681
5.
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
J Neurol Neurosurg Psychiatry
; 84(10): 1138-47, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22933814
6.
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study.
Neurology
; 95(5): e469-e479, 2020 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32636324
7.
Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension.
CNS Drugs
; 30(8): 749-60, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27401882
8.
Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
Mov Disord
; 22(2): 213-9, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17133582
Resultados
1 -
8
de 8
1
Próxima >
>>